E-Health for Zero Infections - Facilitating Access to and Use of HIV Pre-Exposure Prophylaxis (PrEP) in the Netherlands
EZI-PREP
The EZI-PrEP Study: E-Health for Zero Infections - Facilitating Access to and Use of HIV Pre-Exposure Prophylaxis (PrEP) in the Netherlands
1 other identifier
interventional
469
1 country
4
Brief Summary
Offering PrEP care online and reducing the frequency of monitoring may increase access to HIV PrEP. The objective of this study is to assess the non-inferiority of an internet-based HIV PrEP-service and reduced frequency of monitoring visits in comparison to standard-of-care at the Public Health Service in 4 regions in the Netherlands: Amsterdam, Rotterdam-Rijnmond, Haagland and Gelderland-Zuid.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hiv-infections
Started Sep 2021
Typical duration for not_applicable hiv-infections
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 21, 2021
CompletedFirst Submitted
Initial submission to the registry
October 13, 2021
CompletedFirst Posted
Study publicly available on registry
October 26, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedDecember 13, 2024
December 1, 2024
2.5 years
October 13, 2021
December 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Adherence to PrEP regimen
Non-adherence is defined as a PrEP-less and condom-less anal sex act with a casual partner, termed an unprotected act (UA). Self-reported daily data on sexual behaviour, pill intake and condom use are recorded in an electronic diary. Using these data, we will count the number of UAs (n), and the person-months at risk (pmar) per person; this will yield the incidence rate (IR) per person month (= n / pmar). This will be done for each study arm separately.
18 months for each individual study participant
Study Arms (4)
Arm 1: routine PrEP care at the CSH, monitoring 4 times per year (standard-of-care)
NO INTERVENTIONStudy participants in arm 1 follow routine care procedures, i.e. the number of monitoring visits is four times a year. * Experienced PrEP users: first monitoring visit is three months after the enrolment into the study. * PrEP-naïve participants: first monitoring visit is one month after enrolment in the study and start of PrEP use. The second monitoring visit is 2 months after the first monitoring contact (3 months after enrolment).
Arm 2: routine PrEP care at the CSH, monitoring 2 times per year
EXPERIMENTALStudy participants in arm 2 follow routine care procedures but with a reduced frequency of monitoring visits, i.e. the number of monitoring visits is reduced from four to two times a year. Timing of the first monitoring visit differs per PrEP user type: * Experienced PrEP users: first monitoring visit is six months after the enrolment into the study. * PrEP-naïve participants: first monitoring visit is one month after enrolment in the study and start of PrEP use. The second monitoring visit is five months after the first monitoring visit (6 months after enrolment).
Arm 3: online PrEP care, monitoring 4 times per year
EXPERIMENTALStudy participants in arm 3 receive internet-based PrEP care, i.e. video consultations and online-mediated testing for HIV, STIs and renal function, online PrEP ordering and (at home) delivery of PrEP. Monitoring occurs four times per year. * Experienced PrEP users: first monitoring contact is three months after the enrolment into the study. * PrEP-naïve participants: first monitoring contact is one month after enrolment in the study and start of PrEP use. The second monitoring visit is 2 months after the first monitoring contact (3 months after enrolment).
Arm 4: online PrEP care, monitoring 2 times per year
EXPERIMENTALStudy participants in arm 4 receive internet-based PrEP care, i.e. video consultations and online-mediated testing for HIV, STIs and renal function, online PrEP ordering and (at home) delivery of PrEP. Monitoring occurs two times per year. * Experienced PrEP users: first monitoring contact is six months after the enrolment into the study. * PrEP-naïve participants: first monitoring contact is one month after enrolment in the study and start of PrEP use. The second monitoring visit is five months after the first monitoring contact (6 months after enrolment).
Interventions
Variations on routine PrEP care at the Public Health Services in the Netherlands: online PrEP care and reduced frequency of monitoring
Eligibility Criteria
You may qualify if:
- Aged 18 years or older;
- Meeting the eligibility criteria of the NPP i.e. being a MSM or transgender persons who in the 6 months prior to the PrEP-request/PrEP-consultation:
- Had anal sexual intercourse without a condom with a male partner with an un-known HIV status, and/or;
- Had anal sexual intercourse without a condom with a male partner with a known HIV-positive status and a detectable viral load, and/or;
- Was diagnosed with a rectal STI, and/or;
- Received a prescription for post-exposure prophylaxes (PEP);
- Living in the catchment area of one of the participating GGD regions;
- Having a smartphone, internet access and email address;
- Sufficient understanding of Dutch or English; and
- Signed informed consent.
You may not qualify if:
- HIV infection;
- Chronic or acute Hepatitis B virus infection;
- Diminishing renal function:
- eGFR less than 60 mL/min/1.73m2;
- Other renal problems, as diagnosed by a physician and advised against using TFV;
- Chronic use of medication that interacts with TFV/FTC e.g. NSAIDs.
- Other medical conditions that require special attention when using PrEP, such as osteoporosis or other bone diseases;
- Unlikely, in the opinion of the clinician, to comply with the study requirements or procedures;
- Participating in another study that affects the primary or secondary outcome measures of our study;
- Investigators or otherwise dependent persons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Public Health Service of Amsterdamlead
- Public Health Service Rotterdam-Rijnmondcollaborator
- Public Health Service Haaglandencollaborator
- Public Health Service Gelderland-Zuidcollaborator
- The National Institute for STI and Aids Control in the Netherlands (Soa Aids Nederland)collaborator
- Stichting Aidsfondscollaborator
- DC Pharmacy of DC Kliniekencollaborator
Study Sites (4)
Public Health Service of Amsterdam
Amsterdam, 1018 WT, Netherlands
Public Health Service Gelderland-Zuid
Nijmegen, Netherlands
Public Health Service Rotterdam-Rijnmond
Rotterdam, Netherlands
Public Health Service Haaglanden
The Hague, Netherlands
Related Publications (1)
Groot Bruinderink ML, Boyd A, Coyer L, Boers S, Blitz L, Brand JM, Gotz HM, Stip M, Woudstra J, Yap K, Vermey K, Matser A, Feddes AR, Jongen VW, Prins M, Hoornenborg E, van Harreveld F, Schim van der Loeff MF, Davidovich U. Online-Mediated HIV Pre-exposure Prophylaxis Care and Reduced Monitoring Frequency for Men Who Have Sex With Men: Protocol for a Randomized Controlled Noninferiority Trial (EZI-PrEP Study). JMIR Res Protoc. 2023 Nov 8;12:e51023. doi: 10.2196/51023.
PMID: 37938875DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Udi Davidovich, PhD
Public Health Service of Amsterdam
- PRINCIPAL INVESTIGATOR
Maarten Schim van der Loeff
Public Health Service of Amsterdam
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior researcher (PhD)
Study Record Dates
First Submitted
October 13, 2021
First Posted
October 26, 2021
Study Start
September 21, 2021
Primary Completion
March 31, 2024
Study Completion
September 30, 2024
Last Updated
December 13, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share